Zydus Lifesciences initiates phase 4 trial for Saroglitazar Mg in NAFLD
Zydus Lifesciences, an Indian life sciences company, has announced the commencement of Phase IV Real World Data Registry trial “EVIDENCES-XI” for Saroglitazar Magnesium (Mg) in patients with non-alcoholic fatty liver disease (NAFLD) and comorbidities. This late-stage trial aims to evaluate the efficacy of Saroglitazar Mg in approximately 1,500 male and female NAFLD patients, each with […]